1. Home
  2. NAMS vs ACVA Comparison

NAMS vs ACVA Comparison

Compare NAMS & ACVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • ACVA
  • Stock Information
  • Founded
  • NAMS 2019
  • ACVA 2014
  • Country
  • NAMS Netherlands
  • ACVA United States
  • Employees
  • NAMS N/A
  • ACVA N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • ACVA Business Services
  • Sector
  • NAMS Health Care
  • ACVA Consumer Discretionary
  • Exchange
  • NAMS Nasdaq
  • ACVA Nasdaq
  • Market Cap
  • NAMS 2.5B
  • ACVA 2.7B
  • IPO Year
  • NAMS N/A
  • ACVA 2021
  • Fundamental
  • Price
  • NAMS $23.60
  • ACVA $14.54
  • Analyst Decision
  • NAMS Strong Buy
  • ACVA Strong Buy
  • Analyst Count
  • NAMS 9
  • ACVA 11
  • Target Price
  • NAMS $41.11
  • ACVA $22.27
  • AVG Volume (30 Days)
  • NAMS 844.8K
  • ACVA 1.8M
  • Earning Date
  • NAMS 08-06-2025
  • ACVA 08-11-2025
  • Dividend Yield
  • NAMS N/A
  • ACVA N/A
  • EPS Growth
  • NAMS N/A
  • ACVA N/A
  • EPS
  • NAMS N/A
  • ACVA N/A
  • Revenue
  • NAMS $47,140,000.00
  • ACVA $674,164,000.00
  • Revenue This Year
  • NAMS N/A
  • ACVA $24.16
  • Revenue Next Year
  • NAMS N/A
  • ACVA $21.94
  • P/E Ratio
  • NAMS N/A
  • ACVA N/A
  • Revenue Growth
  • NAMS 586.97
  • ACVA 32.89
  • 52 Week Low
  • NAMS $14.06
  • ACVA $11.88
  • 52 Week High
  • NAMS $27.29
  • ACVA $23.46
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 67.01
  • ACVA 33.58
  • Support Level
  • NAMS $22.00
  • ACVA $14.72
  • Resistance Level
  • NAMS $24.82
  • ACVA $15.32
  • Average True Range (ATR)
  • NAMS 1.21
  • ACVA 0.50
  • MACD
  • NAMS 0.25
  • ACVA -0.15
  • Stochastic Oscillator
  • NAMS 77.98
  • ACVA 1.56

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About ACVA ACV Auctions Inc.

ACV Auctions Inc is a mobile platform for wholesale car auctions. The company provides a digital marketplace for wholesale vehicle transactions and data services that offer transparent and accurate vehicle information for customers.

Share on Social Networks: